Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Pharma is going to outperform. Pharma has a long way to go and every dip in these stocks is a buy. I am saying that together with banks it is pharma that could provide the leadership rather than IT."
"Dr Reddy's Labs, Sun Pharma, Cipla, Lupin and Aurobindo Pharma, you just have to close your eyes and pick any of them," he said.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
